-compressed%20(1)1024_1_edited%20(1.jpg)
ULTRAFLUID-BASED NANOICARIDIN
Ultrafluid-based Nanostructured Nanoicaridin is composed of lipid nanoparticles containing the encapsulated active icaridin, with a particle diameter larger than 600 nm. The encapsulation of the active ingredient through the technology developed by Nanovetores allows for the stabilization of sensitive and complex components that are difficult to formulate, as well as greater durability of its properties. Studies have shown that icaridin can be safely used in children. The use of the product promotes the repellency of mosquitoes in general and is highly effective against the Aedes aegypti mosquito, which transmits Zika, Dengue, and Chikungunya.
ICARIDIN
The active ingredient Icaridin is derived from pepper and stands out in the market for its repellency potential against Aedes aegypti, and may have up to 2 times more potency than other active ingredients used in the market. Aedes aegypti is the mosquito that transmits the virus that causes Dengue, Zika and Chikungunya, serious diseases that can cause microcephaly and even death. The use of Icaridin is not restricted to a single group, being possible to use it by children and even women during pregnancy. NanoIcaridina is an active encapsulated in lipid nanoparticles, in order to improve the performance and durability of the active repellent action on the skin in an effective and safe way.
The active Icaridin in the free form applied at a concentration of 10% provides protection for a period of 3 to 5 hours, and at a concentration of 20%, it protects for 8 to 10 hours. Nanovetores encapsulation technology allows an increase in the time of repellent action using reduced concentrations. Clinical tests performed with a formulation containing only 5.5% Icaridin conferred a repellent action against insects for a period of up to 8 hours. The product also did not induce significant or persistent adverse clinical reactions in any volunteer during the study period, being considered safe for both adults and children from 6 months.